Lilly's Cymbalta gets closer to FDA approval

One year after receiving its first conditional approval for its experimental depression medicine, Cymbalta, Eli Lilly said Wednesday it received a second notice from the FDA saying the company does not need to conduct more clinical trials to get approval. However, Lilly still must resolve issues with its plant where Cymbalta will be made.

View Full Article in:

MSNBC · Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations